+44 (0)20 8154 4600
info@achillestx.com
Home
About Us
Science
Publications
Pipeline
News
News
Media Coverage
Events
Work with us
Contact
Home
About Us
Science
Publications
Pipeline
News
Media Coverage
Events
Work with us
Contact
ACHILLES
MEDIA COVERAGE
BioWorld – Achilles’ I-O approach draws $120M in series B
04/09/2019
READ MORE +
Financial Times – UK biotech secures £100m funding for lung cancer trials
03/09/2019
READ MORE +
Endpoints – RA Capital-backed cell therapy player in the neoantigen game grabs a $121M megaround to fund first human studies
03/09/2019
READ MORE +
Scrip – Interview: Achilles Advances Armed With £100m
03/09/2019
READ MORE +
BioCentury – Achilles Adds £100m To Move Neoantigen T Cell Therapy Into The Clinic
03/09/2019
READ MORE +
Wall Street Journal Pro Venture Capital – Achilles Therapeutics Eyes T-Cell Therapy for Solid Cancers With New Funding
03/09/2019
READ MORE +
BioCentury – Achilles’ Truncal Neoantigens
21/01/2019
READ MORE +